News from nuvo research inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Toronto:NRI)

Jan 21, 2016, 07:30 ET

Nuvo Research® Provides Estimated Revenue for the 2015 Fourth Quarter and Year End

MISSISSAUGA, Jan. 21, 2016 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a life sciences company with growing revenues and a diverse portfolio...

Dec 22, 2015, 07:30 ET

Nuvo Research® Reacquires Pliaglis North American Development and Marketing Rights

MISSISSAUGA, ON, Dec. 22, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a life sciences company with growing...

Dec 21, 2015, 07:00 ET

Nuvo Research® Reports Topline Results of Phase 2 Trial of WF10™ for the Treatment of Allergic Rhinitis

- Study fails to demonstrate separation between WF10 and placebo - - Company will discontinue development of WF10 and focus on other pipeline...

Dec 15, 2015, 07:30 ET

Nuvo Research® Announces Special Shareholder Meeting to Vote on Reorganization of Nuvo into Two Publicly Traded Companies

- Mailing of Management Information Circular Expected in January 2016 - MISSISSAUGA, ON, Dec. 15, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI)...

Dec 03, 2015, 07:30 ET

Nuvo Research® Provides Update on Pennsaid® 2% Phase 3 Clinical Trial

- Top line results expected in Q1 2016 - MISSISSAUGA, ON, Dec. 3, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty...

Nov 30, 2015, 07:30 ET

Nuvo Research® Announces Acceleration of Expiry Date of Outstanding Warrants

MISSISSAUGA, ON, Nov. 30, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI) ("Nuvo" or the "Company"), a specialty pharmaceutical company with...

Nov 23, 2015, 07:30 ET

Nuvo Research® Announces TSX Conditional Approval to List Crescita Therapeutics Inc.

MISSISSAUGA, ON, Nov. 23, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI) ("Nuvo" or the "Company"), a specialty pharmaceutical company with...

Nov 10, 2015, 17:00 ET

Nuvo Research® Announces 2015 Third Quarter Results

- Quarter Highlighted by significant Product Sales growth and announcement of Proposed Split into Two Independent Public Companies - MISSISSAUGA,...

Nov 05, 2015, 07:15 ET

Nuvo Research Announces Successful Pennsaid®2% Phase 3 Trial for Russia

MISSISSAUGA, ON, Nov. 5, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing...

Nov 03, 2015, 07:30 ET

Nuvo Research® Announces Appointment to its Board of Directors

MISSISSAUGA, ON, Nov. 3, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing...

Sep 15, 2015, 19:00 ET

Nuvo Research® Announces Intention to Split Into Two Publicly Traded Companies

- Nuvo shareholders to receive shares of both companies - One company would be a profitable and growing commercial business - One...

Aug 20, 2015, 07:30 ET

Nuvo Research® Announces U.S. Patent for Topical Foamed Formulations that Include DMSO

MISSISSAUGA, ON, Aug. 20, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of...

Aug 11, 2015, 07:30 ET

Nuvo Research® Announces Grant of United States Patent for Topical Onychomycosis Formulation

MISSISSAUGA, ON, Aug. 11, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical...

Aug 05, 2015, 17:00 ET

Nuvo Research® Announces 2015 Second Quarter Results

MISSISSAUGA, ON, Aug. 5, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of...

Jun 24, 2015, 07:30 ET

Nuvo Research® Provides Update on International Licensing of Pennsaid® 2%

MISSISSAUGA, ON, June 24, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical...

Jun 08, 2015, 07:30 ET

Nuvo Research® Receives Health Canada Approval to Conduct New WF10™ Phase 2 Trial

MISSISSAUGA, ON, June 8, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of...

May 13, 2015, 17:00 ET

Nuvo Research announces director election results of its Annual General Meeting

MISSISSAUGA, ON, May 13, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company with a diverse portfolio of...

May 12, 2015, 17:00 ET

Nuvo Research® Announces 2015 First Quarter Results

MISSISSAUGA, ON, May 12, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical...

Apr 22, 2015, 07:30 ET

Nuvo Research® Announces New WF10™ Phase 2 Trial

MISSISSAUGA, ON, April 22, 2015 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical...

Apr 16, 2015, 07:30 ET

Nuvo Research® Updates Company Strategy

- Plans to spin-off WF10™ and focus on generating additional revenues - MISSISSAUGA, ON, April 16, 2015 /PRNewswire/ - Nuvo Research Inc....